AOBI OTC
American Oriental Bioengineering, Inc.
1W: +0.0%
1M: +0.0%
3M: +983.3%
YTD: +983.3%
1Y: +1081.8%
3Y: +6400.0%
5Y: -99.5%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$145M
-31.8% ▼
5Y CAGR: -2.0%
Gross Profit
$44M
-55.5% ▼
5Y CAGR: -16.8%
Operating Income
-$55M
-1450.7% ▼
Net Income
-$60M
+12.8% ▲
EPS (Diluted)
$-781.24
+13.4% ▲
EBITDA
-$40M
+18.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|---|
| Revenue | $265M | $296M | $306M | $213M | $145M |
| YoY Growth | +64.9% | +11.9% | +3.3% | -30.5% | -31.8% |
| Cost of Revenue | $91M | $129M | $148M | $113M | $101M |
| Gross Profit | $174M | $167M | $158M | $100M | $44M |
| Gross Margin | 65.6% | 56.3% | 51.6% | 46.9% | 30.6% |
| R&D Expenses | $14M | $8M | $15M | $13M | $6M |
| SG&A Expenses | $93M | $94M | $105M | $66M | $79M |
| Operating Expenses | $97M | $108M | $127M | $143M | $131M |
| Operating Income | $63M | $59M | $30M | -$4M | -$55M |
| Operating Margin | 24.0% | 19.8% | 9.9% | -1.7% | -37.9% |
| Interest Expense | $3M | $6M | $6M | $7M | $6M |
| Income Before Tax | $60M | $55M | $23M | -$68M | -$58M |
| Tax Expense | $13M | $13M | $9M | $635K | $2M |
| Net Income | $47M | $41M | $14M | -$68M | -$60M |
| Net Margin | 17.8% | 14.0% | 4.6% | -32.2% | -41.2% |
| EPS (Diluted) | $611.22 | $1062.12 | $185.37 | $-901.80 | $-781.24 |
| EBITDA | $72M | $73M | $42M | -$49M | -$40M |
| Shares Outstanding | 82089 | 89108 | 75573 | 74682 | 76449 |